Fall Line Capital

A capital firm focused on the agricultural sector, investing in broadacre farmland and agricultural technologies.

Venture Capital Active San Mateo, United States Est. 2011
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages

About

Fall Line Capital is a specialist investment firm with deep roots in the global food system. The firm focuses on investments in US farmland and AgTech startups, aiming to realize untapped productivity in farmland through active management and strategic technology investments. They partner with exceptional founders building technologies that shape critical systems across multiple industries, with a lens for opportunities that intersect the food and agriculture value chain.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Agriculture & Food Technologies3

Q&A

What is Fall Line Capital's primary investment focus?
Fall Line Capital primarily focuses on the Agriculture & Food Technologies sector, with all three of its listed portfolio companies operating in this area.
Can you name some of Fall Line Capital's portfolio companies?
Fall Line Capital's portfolio includes Chunk Foods, which specializes in plant-based whole-cut products.
What was Fall Line Capital's most recent investment?
Fall Line Capital participated in a Seed round for Chunk Foods in April 2023, which raised $24.5M.
What is Fall Line Capital's typical investment stage?
Fall Line Capital has invested in both Seed and B Round stages. Two of its investments have been at the Seed stage, and one at the B Round stage.
When did Fall Line Capital make its first recorded investment?
Fall Line Capital made its first recorded investment in January 2021.
What is the typical investment range for Fall Line Capital?
Fall Line Capital's investment range is between $3.3M and $40M.
Has Fall Line Capital made any investments in companies developing safer food proteins?
Yes, Fall Line Capital invested in Ukko, a company focused on developing safer proteins for people with food allergies and sensitivities. Ukko raised $47.7M in a Series A round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2011